INSIGHTS ON DRUG DEVELOPMENT
-
Innovative Technology For Developing, Scaling Peptide-Based Therapeutics
Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.
-
Target Product Profile (TPP) Explained
Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.
-
qPCR Amplification Of Human Gastrointestinal Samples
Residual inhibitors in GI-derived DNA can hinder qPCR performance. An optimized approach improves inhibitor tolerance and enables earlier target detection, delivering more reliable amplification.
-
Solutions For CQA Analysis Of IVT mRNA-Based Biotherapeutics
Discover new innovative solutions for mRNA analysis, enhancing accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.
-
Context-First Data For Trustworthy AI In Biopharma6/26/2026
Bridge the gap between AI experimentation and enterprise value. Learn how capturing structured, semantically rich data at the point of origin builds regulator-credible AI pipelines.
-
Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk5/18/2026
Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.
-
Column Selection For RPLC-UV Impurity Analysis7/17/2025
Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.
-
High Potency APIs And The Evolving Demands Of Drug Development4/13/2026
See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
-
Seed Train Intensification Using High Cell Density Cryopreservation8/11/2025
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
DRUG DEVELOPMENT SOLUTIONS
-
Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.
-
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
By streamlining the synthesis pathways, see how these products can effectively diminish the requisite number of developmental and manufacturing stages essential for generating payloads.
-
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
Explore how key biomarkers like Amyloid-beta, TAU, and α-Synuclein are transforming neurodegeneration research, with enhanced detection strategies that improve diagnostic accuracy.